98 related articles for article (PubMed ID: 1484741)
1. Lethal and non-lethal course of endotoxic shock is determined by interactions between tumor necrosis factor, platelet activating factor and eicosanoids.
Mozes T; Ben-Efraim S; Bonta IL
Pathol Biol (Paris); 1992 Oct; 40(8):807-12. PubMed ID: 1484741
[TBL] [Abstract][Full Text] [Related]
2. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
[TBL] [Abstract][Full Text] [Related]
3. Sequential release of tumour necrosis factor, platelet activating factor and eicosanoids during endotoxin shock in anaesthetized pigs: protective effects of indomethacin.
Mózes T; Zijlstra FJ; Heiligers JP; Tak CJ; Ben-Efraim S; Bonta IL; Saxena PR
Br J Pharmacol; 1991 Nov; 104(3):691-9. PubMed ID: 1797328
[TBL] [Abstract][Full Text] [Related]
4. Relationships between tumour necrosis factor, eicosanoids and platelet-activating factor as mediators of endotoxin-induced shock in mice.
Myers AK; Robey JW; Price RM
Br J Pharmacol; 1990 Mar; 99(3):499-502. PubMed ID: 2110016
[TBL] [Abstract][Full Text] [Related]
5. Time course of various inflammatory mediators during recurrent endotoxemia.
Klosterhalfen B; Hörstmann-Jungemann K; Vogel P; Flohé S; Offner F; Kirkpatrick CJ; Heinrich PC
Biochem Pharmacol; 1992 May; 43(10):2103-9. PubMed ID: 1599496
[TBL] [Abstract][Full Text] [Related]
6. Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.
Fletcher JR; DiSimone AG; Earnest MA
Ann Surg; 1990 Mar; 211(3):312-6. PubMed ID: 2178565
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
Quinn JV; Slotman GJ
Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269
[TBL] [Abstract][Full Text] [Related]
8. Myoelectric intestinal disturbances in Escherichia coli endotoxic shock in rats. Involvement of platelet-activating factor.
Pons L; Droy-Lefaix MT; Braquet P; Buéno L
Lipids; 1991 Dec; 26(12):1359-61. PubMed ID: 1819734
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of diclofenac sodium against endotoxic shock in anaesthetized pigs.
Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
Prostaglandins Leukot Essent Fatty Acids; 1993 Feb; 48(2):193-200. PubMed ID: 8446657
[TBL] [Abstract][Full Text] [Related]
10. Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
Filep JG; Braquet P; Mózes T
Circ Shock; 1991 Sep; 35(1):1-8. PubMed ID: 1742856
[TBL] [Abstract][Full Text] [Related]
11. The involvement of platelet-activating factor (PAF)-induced monocyte activation and tumor necrosis factor (TNF) production in shock.
Bonavida B; Paubert-Braquet M; Hosford D; Braquet P
Prog Clin Biol Res; 1989; 308():485-9. PubMed ID: 2780710
[No Abstract] [Full Text] [Related]
12. A PAF receptor antagonist, BN 52021, attenuates thromboxane release and improves survival in lethal canine endotoxemia.
Moore JM; Earnest MA; DiSimone AG; Abumrad NN; Fletcher JR
Circ Shock; 1991 Sep; 35(1):53-9. PubMed ID: 1660355
[TBL] [Abstract][Full Text] [Related]
13. Sequential release of eicosanoids during endotoxin-induced shock in anesthetized pigs.
Mózes T; Zijlstra FJ; Heiligers JP; Saxena PR; Bonta IL
Prostaglandins Leukot Essent Fatty Acids; 1991 Apr; 42(4):209-16. PubMed ID: 1651510
[TBL] [Abstract][Full Text] [Related]
14. Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig.
Adnot S; Lefort J; Lagente V; Braquet P; Vargaftig BB
Pharmacol Res Commun; 1986 Aug; 18 Suppl():197-200. PubMed ID: 3774845
[No Abstract] [Full Text] [Related]
15. Role of platelet-activating factor in pancreatitis-associated acute lung injury in the rat.
Zhou W; McCollum MO; Levine BA; Olson MS
Am J Pathol; 1992 Apr; 140(4):971-9. PubMed ID: 1562055
[TBL] [Abstract][Full Text] [Related]
16. Influence of inhibitors of the eicosanoid metabolism, and of eicosanoids- and PAF-acether antagonists on mortality and some biochemical parameters of three shock models.
Bahr T; Schaper U; Becker K; Lueddeckens G; Förster W; Scheuch DW; Grupe R
Prog Clin Biol Res; 1989; 301():229-33. PubMed ID: 2798447
[No Abstract] [Full Text] [Related]
17. Systemic and regional hemodynamic changes during endotoxin or platelet activating factor (PAF)-induced shock in rats.
Mulder MF; van Lambalgen AA; van Kraats AA; Scheffer PG; Bouman AA; van den Bos GC; Thijs LG
Circ Shock; 1993 Dec; 41(4):221-9. PubMed ID: 8143350
[TBL] [Abstract][Full Text] [Related]
18. Leukotrienes in cerebrospinal fluid of the conscious cat: effect of platelet-activating factor and pyrogens.
Coceani F; Bishai I; Lees J; Hynes N
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():480a-d. PubMed ID: 1825586
[No Abstract] [Full Text] [Related]
19. Release of eicosanoids in rat peritoneal cavity during the Arthus reaction. Effect of the PAF-antagonist BN-52021 and indomethacin.
Jancar S; Braquet P; Sirois P
Int J Immunopharmacol; 1989; 11(2):129-32. PubMed ID: 2539337
[TBL] [Abstract][Full Text] [Related]
20. Interactions of arachidonic acid metabolites and platelet activating factor and mechanism of action in hypersensitivity reactions.
Jancar S; Braquet P; Sirois P
Braz J Med Biol Res; 1987; 20(5):487-94. PubMed ID: 2838117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
